Newman James W. Jr. has filed 3 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 28000 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on May 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| March 25, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |